Zacks Investment Research on MSN

Should you buy ANIP as low valuation meets Cortrophin execution risk?

ANI Pharmaceuticals, Inc. ANIP presents a sharp valuation-versus-execution trade-off. The stock trades at a steep discount to ...
Zacks Investment Research on MSN

ANIP's Cortrophin guidance cut raises the bar for second-half growth

ANI Pharmaceuticals, Inc. ANIP topped second-quarter earnings and revenue expectations, but the quarter also exposed a softer ...